 Connection
Lisa Schilling to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Lisa Schilling has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.567 |
|
|
|
-
Dellavalle RP, Drake A, Graber M, Heilig LF, Hester EJ, Johnson KR, McNealy K, Schilling L. Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD003697.
Score: 0.201
-
Reed SM, Austin E, Colborn K, Schilling LM, Kutner JS. Modeling of an alternative reimbursement method for palliative care. Am J Manag Care. 2022 06 01; 28(6):e221-e227.
Score: 0.159
-
Meckley AL, Militello M, Sivesind TE, Schilling L, Dellavalle RP. From the Cochrane Library: Statins and Fibrates for Preventing Melanoma. Dermatology. 2022; 238(4):668-669.
Score: 0.153
-
Freeman SR, Drake AL, Heilig LF, Graber M, McNealy K, Schilling LM, Dellavalle RP. Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. J Natl Cancer Inst. 2006 Nov 01; 98(21):1538-46.
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|